

















Telomeres, the specialized structures at chromosome 
ends, consist of long stretches of protein-bound 
TTAGGG repeats [1].  In certain cell types, such as 
germ  cells  and  stem  cell  populations,  the  length           
of telomeric DNA is maintained by the enzyme telo-
merase. Most somatic cells, however, lack sufficient 
telomerase; consequently, telomeric DNA shortens 
progressively with each cell division. Upon reaching a 
critically short length, proliferation is halted and cells 
often enter a state of senescence. Thus, progressive 
telomere shortening is thought to serve as a molecular 
clock for cellular replicative aging. Based upon this 
fundamental tenet of telomere biology, an ever-
increasing number of studies spanning a wide spectrum 
of human conditions have utilized telomere length, 
typically measured in buccal cells or blood mono-
nuclear cells, as a biomarker for cellular replicative age.  
Individuals with relatively short age-adjusted telomere 
lengths, due to a combination of inherent factors and 
environmental stressors, are considered to have acceler-
ated cellular replicative aging, potentially resulting in 
increased disease susceptibility [2]. 
 
Telomere length is also used as a diagnostic tool in 
diseases characterized by fundamental derangements of 
telomere biology, such as dyskeratosis congenita (DC).   
DC is a rare genetic disorder stemming from a defect in 
telomere maintenance.  This defect results in a broad 
and highly variable clinical phenotype consisting of 
predisposition to bone marrow failure and malignancy, 
a triad of mucocutaneous features, and a number of       
less frequent manifestations such as pulmonary fibrosis 
and liver disease [3]. In nearly all reported cases, affect-  
ted individuals have severely shortened telomeres,           




















encoding  components  of  telomerase  or  a  telo-         
mere-associated protein  in  approximately half  of  cases. 
 
Hence, DC is considered the prototype of a heritable 
disorder of telomere maintenance.  In DC, very short 
telomeres are observed across different classes of 
peripheral white blood cells, affecting both lymphoid 
subpopulations and granulocytes [4].  In contrast, in 
other inherited bone marrow failure syndromes 
(IBMFS), telomere length shortening is less pronounced 
and the effect is largely restricted to granulocytes.   
Rather than being due to an inherent defect in telomere 
maintenance,  the  short  telomeres  in  granulocytes            
in these cases are thought to reflect accelerated 
progenitor/stem cell turnover secondary to bone marrow 
stress.  
 
The utility of telomere length both as a biomarker for 
accelerated cellular replicative aging and as a diag-
nostic marker for a constitutional defect in telomere 
maintenance solicits a question as to how telomere 
length varies in different tissues in conditions associated 
with accelerated cellular aging as compared to disorders 
where telomere length maintenance is compromised.  In 
this issue of Aging, Gadalla, et al, begin to address this 
question by simultaneously examining relative telomere 
length in granulocytes, fibroblasts and buccal cells 
within individuals affected by DC and other IBMFS [5].  
Although the number of subjects was small, strong 
correlations between blood, buccal cells, and fibroblasts 
were observed in the study population as a whole.   
When taken individually, however, only cells from 
subjects with DC demonstrated significant correlation.  
Telomere  shortening  in  different  cell  types  has         
been described previously in  DC [4,6,7],  however,  the  
Measuring relative telomere length: Is tissue an issue?   
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subjects examined in this study demonstrates the global 
defect in telomere maintenance in this disorder.   
Notably, relative telomere length was longer in fibro-
blasts and buccal cells when compared to granulocytes 
across each specific IBMFS, perhaps reflecting the 
replicative histories of these cell types. Though 
significant intra-individual telomere length correlation 
between disparate tissue types has been observed in 
healthy subjects [8-13], few studies involving subjects 
with disease have evaluated telomere length in multiple 
tissues.  By demonstrating such correlations within the 
DC population, Gadalla et al. provide evidence to 
support the use of relative telomere length in readily 
accessible cells such buccal or blood as a surrogate for 
inherent telomere maintenance  capacity. 
 
A higher proportion of single nucleotide variants within 
specific telomerase-associated genes, such as TERT and 
TERC, which encode the catalytic and RNA subunits of 
telomerase, respectively, have been described in cases 
with  disease  compared  with  a  control  population       
[14-19]. Interestingly, some variants have been 
described in familial cohorts with a predominant single 
phenotype, such as non-alcoholic liver disease or 
idiopathic pulmonary fibrosis, whereas the broader 
spectrum of the DC-associated phenotypes is not 
observed [16,20,21]. The impact of many of these 
variants on telomere maintenance has been inferred by 
measuring telomerase activity following transfection of 
the variant alleles into TERT or TERC-deficient cell 
lines, and by measuring telomere length, most often in 
leukocytes.  Examining multiple tissue types in these 
cases of isolated phenotypes, similar to the approach of 
Gadalla, et al, may lend further support to the under-
lying impact of these telomerase gene variants on 
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